During the past decade, Marin Cancer Care Inc conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 42 clinical trials were completed, i.e. on average, 91.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 24 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marin Cancer Care Inc" #1 sponsor was "National Cancer Institute (NCI)" with 27 trials, followed by "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "Exact Sciences Corporation" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Incyte Corporation" with 3 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marin Cancer Care Inc" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "Marin Cancer Care Inc" are "Breast Cancer" (6 trials), "Colorectal Cancer" (5 trials), "Ovarian Seromucinous Carcinoma" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Breast Adenocarcinoma" (3 trials). Many other conditions were trialed in "Marin Cancer Care Inc" in a lesser frequency.

Most popular intervention types in "Marin Cancer Care Inc" are "Drug" (67 trials), "Other" (36 trials), "Biological" (27 trials), "Procedure" (11 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Paclitaxel" (15 trials), "Carboplatin" (11 trials), "Quality-of-Life Assessment" (11 trials) and "Bevacizumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "Marin Cancer Care Inc" are 62 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Marin Cancer Care Inc". undefined are not yet recruiting, 17 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Marin Cancer Care Inc, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Marin Cancer Care Inc, 3 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Marin Cancer Care Inc has several departments that took part in Clinical trials: "California Cancer Care Inc" - 36 trials, "California Cancer Care" - 17 trials, "Marin Oncology Associates" - 4 trials